{"text": ["Spark", "Therapeutics'", "Luxturna", "Gets", "EU", "Approval", "for", "Vision", "Loss"], "created_at": "2018-11-26 22:06:44"}
{"text": ["Spark", "Therapeutics'", "Luxturna", "Gets", "EU", "Approval", "for", "Vision", "Loss"], "created_at": "2018-11-26 22:06:44"}
{"text": ["Spark", "Therapeutics'", "Luxturna", "Gets", "EU", "Approval", "for", "Vision", "Loss"], "created_at": "2018-11-26 20:16:08"}
{"text": ["4", "Reasons", "Why", "Lilly", "is", "Up", "More", "Than", "30%", "This", "Year", "So", "Far"], "created_at": "2018-11-26 17:09:11"}
{"text": ["4", "Reasons", "Why", "Lilly", "is", "Up", "More", "Than", "30%", "This", "Year", "So", "Far"], "created_at": "2018-11-26 17:09:11"}
{"text": ["Endocyte", "Stock", "Has", "Seen", "a", "Solid", "Hike", "in", "2018"], "created_at": "2018-11-26 16:33:35"}
{"text": ["Health", "Care", "Digest:", "Genentech&apos;s", "blood", "cancer", "win,", "a", "boost", "for", "Gilead&apos;s", "HIV", "PrEP", "and", "a", "tiny", "IPO", "swings", "at", "antibiotics"], "created_at": "2018-11-26 15:04:07"}
{"text": ["Novartis", "CEO:", "4", "factors", "can", "help", "the", "industry", "price", "and", "pay", "for", "lifesaving", "cell", "and", "gene", "therapies"], "created_at": "2018-11-26 15:00:00"}
{"text": ["Novartis", "CEO:", "4", "factors", "can", "help", "the", "industry", "price", "and", "pay", "for", "lifesaving", "cell", "and", "gene", "therapies"], "created_at": "2018-11-26 15:00:00"}
{"text": ["4", "Reasons", "Why", "Lilly", "is", "Up", "More", "Than", "30%", "This", "Year", "So", "Far"], "created_at": "2018-11-26 14:43:02"}
{"text": ["European", "approval", "of", "Spark", "Therapeutics&apos;", "gene", "therapy", "triggers", "$25M", "payment"], "created_at": "2018-11-26 12:25:17"}
